Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. | Lexicon Pharmaceuticals ...
Mexico has handled the cartels so poorly that it broke international law. It is obligated to prevent the harm cartels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback